en

PRODUCT DETAIL

Febuxostat Krka 80 mg filmom obalené tablety

Code 1230D
MA number EU/1/18/1347/002
Product Form: tbl flm 28x80 mg (blis.PVC/PVDC/PVC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
M MUSCULO-SKELETAL SYSTEM
M04 ANTIGOUT PREPARATIONS
M04A ANTIGOUT PREPARATIONS
M04AA Preparations inhibiting uric acid production
M04AA03 Febuxostat
Shelf life: 24
Container: blister PVC/PVDC/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.03.2019
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 04.01.2024
eu-flag.png sk-flag.png